CLINICAL_TRIALS
trial_result
· 2018-05-04
Clinical Trial Update: A Multi-Center Open-Label Evaluation of the Safety of Sarecycline Tablets in the Treatment of Acne Vulgaris [Phase 3]
Summary
Phase 3 open-label study evaluating the safety of Sarecycline tablets for acne vulgaris. Results posted from a multi-center trial.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Almirall, S.A. | Conditions: Acne Vulgaris | Phase 3 | Status: COMPLETED | Results posted: 2018-05-04